Advertisement
Screener

DNA X, Inc. (SONM) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

DNA X, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

DNA X, Inc. (SONM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 7.36 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.

Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-20

  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 7.36K shares.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 0.00 shares.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 8.78K shares.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-06-30 was 5.45K shares, a 95.60% decline year-over-year.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 15.30K shares, a 33.96% decline from fiscal 2021.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 23.17K shares, a 54.64% decline from fiscal 2020.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 51.08K shares, a 72.58% decline from fiscal 2019.
  • DNA X, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 186.27K shares, a 25.26% decline from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2026-03-317.36K shares
10-Q · filed 2026-05-20
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
8.78K shares
derived: sum of 2 quarters · filed 2024-03-27
14.23K shares
derived: sum of 3 quarters · filed 2024-03-27
15.30K shares
10-K · filed 2024-03-27
2022-09-308.78K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
14.23K shares
derived: sum of 2 quarters · filed 2022-11-14
15.30K shares
10-Q · filed 2022-11-14
15.30K shares
derived: sum of 4 quarters · filed 2023-03-20
2022-06-305.45K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
6.52K shares
10-Q · filed 2022-08-12
6.52K shares
derived: sum of 3 quarters · filed 2023-03-20
-98.38K shares
derived: sum of 4 quarters · filed 2023-03-20
2022-03-311.07K shares
10-Q · filed 2022-05-10
1.07K shares
derived: sum of 2 quarters · filed 2023-03-20
-103.83K shares
derived: sum of 3 quarters · filed 2023-03-20
20.07K shares
derived: sum of 4 quarters · filed 2023-03-20
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-20
-104.90K shares
derived: sum of 2 quarters · filed 2023-03-20
18.99K shares
derived: sum of 3 quarters · filed 2023-03-20
23.17K shares
10-K · filed 2023-03-20
2021-09-30-104.90K shares
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2022-06-29
18.99K shares
derived: sum of 2 quarters · filed 2022-06-29
23.17K shares
10-Q/A · filed 2022-06-29
-430.06K shares
derived: sum of 4 quarters · filed 2022-06-29
2021-06-30123.89K shares
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-06-29
128.07K shares
10-Q/A · filed 2022-06-29
-325.16K shares
derived: sum of 3 quarters · filed 2022-06-29
-237.21K shares
derived: sum of 4 quarters · filed 2022-06-29
2021-03-314.18K shares
10-Q · filed 2021-05-11
-449.05K shares
derived: sum of 2 quarters · filed 2022-06-29
-361.10K shares
derived: sum of 3 quarters · filed 2022-06-29
-223.53K shares
derived: sum of 4 quarters · filed 2022-06-29
2020-12-31-453.23K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-06-29
-365.28K shares
derived: sum of 2 quarters · filed 2022-06-29
-227.71K shares
derived: sum of 3 quarters · filed 2022-06-29
51.08K shares
10-K/A · filed 2022-06-29
510.75K shares
10-K · filed 2021-03-18
2020-09-3087.95K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
225.52K shares
derived: sum of 2 quarters · filed 2020-11-12
504.31K shares
10-Q · filed 2020-11-12
539.84K shares
derived: sum of 4 quarters · filed 2021-03-18
2020-06-30137.57K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
416.36K shares
10-Q · filed 2020-08-12
451.89K shares
derived: sum of 3 quarters · filed 2021-03-18
536.54K shares
derived: sum of 4 quarters · filed 2021-03-18
2020-03-31278.79K shares
10-Q · filed 2020-05-14
314.33K shares
derived: sum of 2 quarters · filed 2021-03-18
398.97K shares
derived: sum of 3 quarters · filed 2021-03-18
461.53K shares
derived: sum of 4 quarters · filed 2021-03-18
2019-12-3135.54K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
120.18K shares
derived: sum of 2 quarters · filed 2021-03-18
182.74K shares
derived: sum of 3 quarters · filed 2021-03-18
186.27K shares
10-K · filed 2021-03-18
2019-09-3084.65K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
147.20K shares
derived: sum of 2 quarters · filed 2019-11-12
150.73K shares
10-Q · filed 2019-11-12
2019-06-3062.55K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
66.08K shares
10-Q · filed 2019-08-13
2019-03-313.53K shares
10-Q · filed 2019-06-24
2018-12-31249.21K shares
10-K · filed 2020-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
CLEARONE INC (CLRO)United States$0.009B
FRANKLIN WIRELESS CORP (FKWL)United States$0.028B-61.80
FiEE, Inc. (FIEE)Japan$0.033B8.06
Clearfield, Inc. (CLFD)United States$0.415B-74.88
ADTRAN Holdings, Inc. (ADTN)United States$0.565B-43.25
Fabrinet (FN)$14.287B39.79
CIENA CORP (CIEN)United States$50.874B81.72